WeChat Share

Details


Bridging Innovation and Entrepreneurship

in Medical Device and Diagnostics


 The 2015 Medical Device & Diagnostics Symposium aims to build a platform of interaction for biomedical professionals in the New England area, highlight innovation and marketing trends, and uncover opportunities for entrepreneurship in both US and China.

   

Highlights 

·        Cutting-edge Innovation in the Medical Device & Diagnostics Industry

·        Market Trends and Industry Outlook

·         Panel discussion on Medical Device & Diagnostics in the US and China


Presented by: 

Chinese-American BioMedical Association (CABA) 美中生物医药协会

New England Chinese Information and Networking Association (NECINA) 紐英倫中華資訊網路協會

128CUTE 128 华人科技协会




Symposium Orgainizing Committee

Chair

Wei Zhang (CABA)

Co-Chairs

Jingzhong Zhang    Ellen Fan    Ru Zheng   Jianfeng(Jeff) Hang   Zhiyong Yang

Committee

Jian Shao    Xiaoyong Zhao    Bo Ying    Qingqing Cao     Liping Zhou    Jeannie Li


Venue: Harvard Pilgrim Health Care, 93 Worcester St. Wellesley, MA 02481 

(We sincerely thanHarvard Pilgrim Health Care foprovidinevenvenue and facility.)





Send us an email if you have any questions:


Wei Zhang          zhangwei999@hotmail.com

Qingqing Cao    qingqingcao117@gmail.com



Symposium Agenda

12:30pm -1:00pm           Registration and Networking

 

1:00pm -1:05pm             Symposium Opening Remark     Wei Zhang (CABA)

 

SESSION I - BUSINESS ON MEDICAL DEVICE           Moderator:  Qingqing Cao , PhD and Jian Shao, MBA

 

1:05am - 1:50pm                         Global Strategy in Medical Device Business (tentative)

David Wang, Head of Corporate Strategy, Covidien

 

1:50pm - 2:20pm                  The De Novo Pathway to Medical Device Market:Strategies and Tactics to Use and Avoid    

                                                Mike Drues, Ph.D., President, Vascular Sciences

 

2:20pm - 2:35pm             The State Role:How the Massachusetts Life Sciences Center Helps Medtech Entrepreneurs Succeed

                                                     Angus McQuilken, Vice President, Massachusetts Life Science Center

 

2:35pm – 3:05                             US-China Medical Device Marketing Strategy 

Grace Fu Palma, MBA, CEO, China Medical Device

 

3:05pm - 3:20pm                         Coffee Break, Networking

 

SESSION IICUTTING EDGE TECHNOLOGIES      

Moderator: Jeff Hang, Ph.D. and Jeannie Li, Ph.D.

 

3:20pm - 3:50 pm                       Eastern Harmony Project (tentative)

Shani Dowd, Director of Culture InSight, Harvard Pilgrim Healthcare           

 

3:50pm - 4:20pm                         Molecular Diagnostics Application (tentative)

Hongshan Li, Ph.D., General Manager, QFW Consulting Company

 

4:20pm - 4:50pm                        Chemical Sensors and Biosensors in POCT

Jingzhong Zhang, Professional Private

 

SESSION III - BUSINESS ON MEDICAL DEVICE       

Moderator: Ru Zheng, MBA

 

4:50pm - 5:30pm                        Panel Discussion

Regina Au, Hongshan Li, Shen Luan, Liang Yang, Xiaodong Wu

 

5:30pm - 6:00pm                                                             Networking


活动简介

2015 CABA 医疗器械与诊断技术研讨会在波士顿的卫斯理镇的Harvard Pilgrim Healthcare 总部大楼召开。93 Worcester Street, Wellesley, MA 02481.

时间为2015年1月24日(周六)下午1:00到下午5:30。

演讲者有来自麻州生命科学中心,世界五百强的医疗器械公司Covidien, Harvard Pilgrim Healthcare, 美中医疗器械产品高级管理官员和负责人,市场专家及技术大牛,startup技术创新公司。欢迎参加。


SPEAKERS

David Wang
Covidien, Vice President of Corporate Strategy
David Wang currently serves as Vice President of Strategy, Insights and Portfolio Management for Covidien Corporate. Previously, David was Vice President of Strategy and BD&L for both Surgical Solutions Group and Vascular Therapies. He joined Covidien in 2010 after holding positions of increasing global marketing and strategic responsibility in the Cordis cardiovascular and DePuy neuroscience businesses of Johnson & Johnson. Before joining Johnson & Johnson in 2003, David served in various leadership positions at McKinsey & Company and at the University of Chicago’s Biological Sciences Division of Academic Computing in Bioinformatics. David received both his bachelor’s degree in biological sciences and Master of Business Administration degree in finance from the University of Chicago.
Michael Drues
President , Vascular Sciences
Michael Drues, Ph.D., is President of Vascular Sciences, an education, training, & consulting company offering a broad range of services to medical device, pharmaceutical & biotechnology companies including (but not limited to): stimulating & innovative educational programing, brain-storming sessions, prototype design, product development, benchtop & animal testing, regulatory strategy, intelligence & clinical trial design, FDA presentation preparation & defense, reimbursement, clinical acceptance, business development & technology assessment. Dr. Drues received his B.S., M.S., and Ph.D. degrees in Biomedical Engineering from Iowa State University in Ames, Iowa. He has worked for and consulted with leading medical device, pharmaceutical and biotechnology companies ranging in size from start-ups to Fortune 100 companies. He also works on a regular basis for the U.S. Food and Drug Administration (FDA), Health Canada, the US and European Patent Offices, the Centers for Medicare and Medicaid Services (CMS) and other regulatory and governmental agencies around the world. Dr. Drues is an internationally recognized expert and featured keynote speaker on cutting-edge medical technologies and regulatory affairs. He conducts seminars and short-courses for medical device, pharmaceutical and biotechnology companies, the U.S. Food and Drug Administration (FDA), Health Canada, the US and European Patent Offices, the US Centers for Medicare and Medicare Services (CMS) and other regulatory and governmental agencies around the world. Current offerings include: Finally, Dr. Drues is an Adjunct Professor of Medicine, Biomedical Engineering & Biotechnology at several universities and medical schools. He regularly teaches graduate courses in Regulatory Affairs and Clinical Trials, Clinical Trial Design, Medical Device Regulatory Affairs and Product Development, Combination Products, Pathophysiology, Medical Technology, Translational Medicine and Biotechnology.
Angus McQuilken
Vice President, Massachusetts Life Sciences Center
Angus McQuilken joined the Massachusetts Life Sciences Center (MLSC) in 2008, and he currently serves as Vice President for Communications & Marketing. In this capacity he oversees media relations, electronic communications, event coordination, trade shows and other marketing activities. Prior to his work at the MLSC, Angus served as Vice President for Public Affairs for Planned Parenthood League of Massachusetts, as Deputy Communications Director for the Democratic National Convention Committee, and as Chief of Staff for State Senator Cheryl Jacques. Angus holds a BA in political science from the University of Massachusetts Amherst. In 2008 he received the Distinguished Citizen Award from the Massachusetts chapter of the American Society for Public Administration. He enjoys basketball, long-distance bicycling and politics.
Grace Fu
CEO, China Med Device
Grace Fu Palma—Founder and CEO of China Med Device, a consulting firm specializing in raising funds and commercialization for early stage (prototype onwards) and small companies in medical device industry between the West and China. She is also founder of Chinese American Heart Association (www.cnaha.org), a 500+ member society consisting of clinicians and researchers with Chinese origins in the cardiovascular medicine from both the United States and China With 20 years of experience in medical device in the United States and China at both large multinationals and start-up companies, she held a variety of marketing and sales management positions from marketing manager to Vice President of marketing and sale. At Hewlett Packard Medical Products and Philips Healthcare, she held the positions of north America marketing managers responsible for product definition research and development, launches, product commercialization planning and execution with product revenues in the hundreds of millions across the spectrum of radiology, cardiology, critical care and point of care clinical areas through a wide range of diagnostic medical equipment and supplies. She managed Hewlett Packard's the first medical production line transfer to China in the early 90s. As the head of Asia Pacific business at the start-up, she grew revenue from zero to millions by recruiting and managing indirect channels and partners’ alliances in China and Asian countries without any budget, turning around money-losing countries into profit centers. She also spearheaded a fundamental strategic transformation from a technology-focused direction to a customer-concentric market segment driven approach with detailed execution plan. She also led and managed sales and clinical team to meet annual targets and work through partners and alliances to cover large territories efficiently, built and managed OEM/indirect channels with multiple industry leaders to create and expand distribution and market awareness in surgery, intervention, and cancers. She has a BA degree from Beijing University in Beijing, China, and an MBA from Yale University in New Haven, CT.
Shani Dowd
Harvard Pilgrim Healthcare, Director of Culture InSight
Shani Dowd has spent most of her career as a mental health clinician, providing services to adults, adolescents, children and their families in a variety of mental health settings. She has lectured widely on issues involving the treatment of members of ethnic minority groups, and she helps train mental health clinicians, predominantly psychologists. In the past fifteen years, Shani has focused her work at the "macro" level: working to improve the care provided to populations affected by health disparities here in the US. She has worked on policy issues at the local and national level, and has worked with a wide range of community groups over the years. She is a member of the faculty of the Center for Multicultural Training in Psychology (CMTP) at Boston University School of Medicine (CMTP is the oldest APA approved pre-doctoral internship program with a primary focus on training psychologists to work with underserved populations). Presently, in her work as Director of Culture InSight, at the Harvard Pilgrim Health Care Foundation, she works with organizations to assist them in addressing issues related to health Disparities as part of our Partnering for Healthy Communities program. Her specialties include: mental health treatment in minority populations, organizational work in diversity and cultural competency
Hongshan Li
General Manager, QFW Consulting Company
Dr. Hongshan Li has more than 20 years of experience in the development and optimization of biomarker detection platforms. Currently he is President of 128 Chinese Union of Technology Enterprises and General Manager of QFW consulting group. Previously, Dr. Li was senior application specialist in Quanterix which is a life science company commercializing a revolutionary Simoa technology and platform for ultrasensitive protein detection. From 2011 to 2013, Dr. Li was a global technical support specialist for BioScale’s novel non-optical detection and quantitation technology. Dr. Li was technical Lead and Senior Principal Scientist at Pall Corporation and was responsible for the development and execution of research projects for proteomics, diagnostics tool, chromatography products and applications development. Prior to joining Pall, he was Senior Application Specialist at Corning LifeSciences providing instrumentation and application of Epic label-free technology for HT drug screening. He also served as a program manager of Ciphergen applying genomics/proteomics research experience and hardware/software expertise to provide expert international technical support to both industry and academia. Dr. Li obtained his Ph.D. in Food Chemistry and Nutrition at Beijing Agricultural University in 1996.
Shen Luan
Director of Regulated Products, Thermo Fisher Scientific
Dr. Shen Luan is currently Director of Regulated Products at Thermo Fisher Scientific. Previously, he served as the President and CTO after co-founding Berg Diagnostics (now part of Berg) in 2010 and was named as COO in 2011. He led efforts on molecular profiling, pan-omics, CLIA-certified clinical diagnostics laboratory services, and overall technology management related to business operations. Prior to Berg, Dr. Luan was the Technical Product Manager of Waters Corporation for 5 years responsible for LC/MS system solutions and laboratory informatics and participated in the ISO13485 compliance program. Dr. Luan started his career with Thermo Fisher Scientific (originally Thermo Jarrell Ash Corporation) and held various management positions including Engineering Manager, Research Manager, and Product Manager during his 9 years there. Dr. Luan received a Ph.D. in Analytical Chemistry from Professor Robert Samuel Houk of Iowa State University and a B.S. in Chemistry from Peking University. He holds a Lean - Six Sigma Black Belt certificate. He is a member of BayHelix, an invitation-only organization of leaders of Chinese heritage in the global life sciences and healthcare community.
Regina Au
Strategic Marketing Consultant, BioMarketing Insight
Ms. Au has over 20 years’ experience in the biotechnology, pharmaceutical, medical device, and diagnostic industries. She helps companies evaluate their technology upfront by conducting an in-depth business due diligence to de-risk the product development process. This ensures that the technology is the right product for the right market in meeting a critical unmet need and that the market potential for the product meets the business goals of the company. She will translate these unmet needs into a product profile or specification. Ms. Au then develops marketing strategies to ensure a successful product launch and product adoption. Ms. Au also serves as an advisor for the Massachusetts Technology Transfer Center Platform Meetings and as a mentor for "Entrepreneurs for All" (formerly Merrimack Valley Sandbox) with entrepreneurs. She has written and published numerous articles on market trends in the industry. Her expertise is in various therapeutic areas such as cardiology, interventional cardiology, infectious disease, immunology, surgery, gastroenterology, and pulmonology. Prior to BioMarketing Insight she worked for companies such as Merck & Co., Genzyme Corp., NMT Medical, and Radi Medical Systems (now St. Jude Medical) in various positions of increasing responsibility in marketing and sales. She had P&L responsibility in managing a number of multimillion dollar product lines and has experience in upstream and downstream marketing including strategic marketing, product development, market development, product launches, and product management. Her background includes an MBA in Marketing from the University of Connecticut, a Microbiology degree from the University of Michigan and a Masters in International Management from Thunderbird School of Global Management.
Liang Yang
President & CEO, Bio-Detail Corporation
Dr. Liang Yang-President and CEO of Bio-Detail Corporation in Worcester, MA. He founded the company in 2013 and has run the company for one more year. Previously, Dr. Yang was an assistant professor at Department of Neuroscience and Physiology, Upstate Medical University, SUNY, Syracuse, New York. He had research experiences in several areas including biochemistry, molecular and cellular biology, neuroscience, behavior biology, chronic pain, obesity and diabetes. Dr. Yang conducted postdoctoral research at John Hopkins Medicine School and MIT. He has published more than 10 original research articles. Dr. Yang obtained his Ph.D. in Neurobiology from the Chinese Academy of Science.
Xiaodong Wu
PhD, Consultant
Dr. Wu is a consultant in genetic technology. Most recently he helped Good Start Genetics, a genetic testing company specializing in carrier screen using next generation sequencing technology, develop new technology in genetic testing for a number diseases. Previously Dr. Wu was a Senior Manager of Clinical Research and Senior Clinical Research Scientist at Interleukin Genetics, Inc. He ran clinical studies in several disease areas including osteoarthritis, periodontitis, osteoporosis and heart disease and helped the company develop two commercial products. Dr. Wu conducted postdoctoral research at Harvard Medical School and Massachusetts General Hospital. He has published more than 20 original research articles. Dr. Wu holds a B.S. in Biology and an M.S. in Ecology from East China Normal University. He obtained a Ph.D. in Cellular and Molecular Neurobiology from the Medical College of Ohio.

Registration

Type Sales End Price Quantity

CABA member

2015-01-24 17:30 $0

non-CABA member, student

2015-01-24 17:30 $15

non-CABA member

2015-01-24 17:30 $30

Contact Us

Your Name: *
Your Email: *
Cell phone:
Subject: *
Message: *